Swedish innovation granted US clearance: FDA clears Swedish ADHD test

The US Food and Drug Administration (FDA) has cleared the neuropsychological test – QbTest – developed by the Swedish company Qbtech to aid in assessing individuals with the functional disorder, ADHD. QbTest is a computer-based test, which provides clinicians with objective and validated decision-making support when diagnosing and treating ADHD in children, adolescents and adults. QbTest is the first test of its kind to have been cleared by the FDA.Approximately 90 000 patients have undergone a QbTest in Europe. Making an ADHD diagnosis requires a thorough assessment, as there is no single